Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.
Price, Matthew J
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. [electronic resource] - American heart journal May 2009 - 818-24, 824.e1 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
1097-6744
10.1016/j.ahj.2009.02.012 doi
Clopidogrel
Coronary Angiography
Dose-Response Relationship, Drug
Double-Blind Method
Drug-Eluting Stents
Electrocardiography
Graft Occlusion, Vascular--blood
Humans
Male
Myocardial Ischemia--blood
Myocardial Revascularization--methods
Platelet Activation--drug effects
Platelet Aggregation Inhibitors--administration & dosage
Postoperative Care--methods
Prospective Studies
Ticlopidine--administration & dosage
Time Factors
Treatment Outcome
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. [electronic resource] - American heart journal May 2009 - 818-24, 824.e1 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
1097-6744
10.1016/j.ahj.2009.02.012 doi
Clopidogrel
Coronary Angiography
Dose-Response Relationship, Drug
Double-Blind Method
Drug-Eluting Stents
Electrocardiography
Graft Occlusion, Vascular--blood
Humans
Male
Myocardial Ischemia--blood
Myocardial Revascularization--methods
Platelet Activation--drug effects
Platelet Aggregation Inhibitors--administration & dosage
Postoperative Care--methods
Prospective Studies
Ticlopidine--administration & dosage
Time Factors
Treatment Outcome